SOAT1 and myeloid sarcoma: The increased phosphorylation response that we observe in MS patients appears not to be related to the cumulative disease susceptibility variants each individual carries either globally (MSGB), stratified by relevant ontological pathways (MSPBphos, MSPBregphos), or the individual risk variants in the proximity of STAT genes.